)
Amber N. Freed
Founder & Mother
SLC6A1 Connect
Ms. Freed is the Founder and CEO of SLC6A1 Connect. Beyond her role as a successful leader, Ms. Freed is a devoted mother to adorable twins, Miss Riley James and Mr. Maxwell Norman. The journey with Maxwell's diagnosis of SLC6A1, a rare neurological disease, became a turning point in Ms. Freed's life. With unwavering determination, she left her career in equity research analysis on the day of Maxwell's diagnosis, committing herself to the mission of finding a cure.
Over the course of a few years, Amber has not only navigated the challenges of rare diseases but has also taken on the task of repurposing a drug and succeeding in driving a first in human gene therapy trial. Her dedication and accomplishments have positioned her as a prominent leader within the rare disease community. Join us in this webinar as Ms. Freed shares her inspiring story, insights into her journey, and the impactful work being done at SLC6A1 Connect.
Sessions
-
23-Jun-2026Storytelling Stage (Booth #3035)Voices from Biotech: Amber N. Freed, Founder & Mother, SLC6A1 Connect
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}